Patents by Inventor Jenifer LUM

Jenifer LUM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
    Publication number: 20240294884
    Abstract: Provided are vaccines, polypeptides and polynucleotides based on mutant CALR and JAK2 sequences, vectors, host cells, viruses, and methods of making and using them. The disclosure also provides methods of inducing an immune response and methods of treating, preventing, reducing a risk of onset or delaying the onset of a clinical condition characterized by an expression of JAK2V617F or CALR exon 9 mutant, or both JAK2V617F and CALR exon 9 mutant, wherein the method comprises a plurality of administrations of any of the compositions comprising polynucleotides, polypeptides or vectors disclosed herein.
    Type: Application
    Filed: May 14, 2024
    Publication date: September 5, 2024
    Inventors: Ricardo ATTAR, Jason DEHART, Selina KHAN, Vinod KRISHNA, Jenifer LUM, Christian MAINE, Barbara SANDERS, Manuel Alejandro SEPULVEDA, Patrick WILKINSON, Roland ZAHN
  • Vaccines based on mutant CALR and JAK2 and their uses
    Patent number: 12018289
    Abstract: Provided are vaccines, polypeptides and polynucleotides based on mutant CALR and JAK2 sequences, vectors, host cells, viruses, and methods of making and using them. The disclosure also provides methods of inducing an immune response and methods of treating, preventing, reducing a risk of onset or delaying the onset of a clinical condition characterized by an expression of JAK2V617F or CALR exon 9 mutant, or both JAK2V617F and CALR exon 9 mutant, wherein the method comprises a plurality of administrations of any of the compositions comprising polynucleotides, polypeptides or vectors disclosed herein.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: June 25, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Ricardo Attar, Jason Dehart, Selina Khan, Vinod Krishna, Jenifer Lum, Christian Maine, Barbara Sanders, Manuel Alejandro Sepulveda, Patrick Wilkinson, Roland Zahn
  • VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
    Publication number: 20210222133
    Abstract: Provided are vaccines, polypeptides and polynucleotides based on mutant CALR and JAK2 sequences, vectors, host cells, viruses, and methods of making and using them. The disclosure also provides methods of inducing an immune response and methods of treating, preventing, reducing a risk of onset or delaying the onset of a clinical condition characterized by an expression of JAK2V617F or CALR exon 9 mutant, or both JAK2V617F and CALR exon 9 mutant, wherein the method comprises a plurality of administrations of any of the compositions comprising polynucleotides, polypeptides or vectors disclosed herein.
    Type: Application
    Filed: November 13, 2020
    Publication date: July 22, 2021
    Inventors: Ricardo ATTAR, Jason DEHART, Selina KHAN, Vinod KRISHNA, Jenifer LUM, Christian MAINE, Barbara SANDERS, Manuel Alejandro SEPULVEDA, Patrick WILKINSON, Roland ZAHN